Your browser doesn't support javascript.
loading
Tumor-intrinsic determinants of immunogenic cell death modalities.
Workenhe, Samuel T; Pol, Jonathan; Kroemer, Guido.
Afiliação
  • Workenhe ST; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
  • Pol J; Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.
  • Kroemer G; Inserm U1138, Paris, France.
Oncoimmunology ; 10(1): 1893466, 2021 03 02.
Article em En | MEDLINE | ID: mdl-33717656
ABSTRACT
The immune system can recognize tumor cells to mount antigen-specific T cell response. Central to the establishment of T cell-mediated adaptive immunity are the inflammatory events that facilitate antigen presentation by stimulating the expression of MHC and costimulatory molecules and the secretion of pro-inflammatory cytokines. Such inflammatory events can be triggered upon cytotoxic treatments that induce immunogenic cancer cell death modalities. However, cancers have acquired a plethora of mechanisms to subvert, or to hide from, host-encoded immunosurveillance. Here, we discuss how tumor intrinsic oncogenic factors subvert desirable intratumoral inflammation by suppressing immunogenic cell death.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Morte Celular Imunogênica / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Morte Celular Imunogênica / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article